Successful Delayed Hyperbaric Oxygen Therapy and Iloprost Treatment on Severe Frostbite at High Altitude | Canada Hyperbarics Skip to main content
Case Report High Alt Med Biol 2022

Successful Delayed Hyperbaric Oxygen Therapy and Iloprost Treatment on Severe Frostbite at High Altitude

Magnan D, Gelsomino M, Louge P, Pignel R — High Alt Med Biol, 2022

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers described the successful delayed hyperbaric oxygen therapy and iloprost treatment for severe frostbite in a 36-year-old man.

What They Found

A 36-year-old man with grade 3 frostbite on both hands, treated with iloprost for 7 days and daily hyperbaric oxygen therapy for 3 weeks starting on day 3, experienced complete healing in less than one month. He avoided amputation, and at 4-year follow-up, showed no clinical arthritis and was able to resume climbing and playing volleyball.

What This Means for Canadian Patients

This case report suggests that a combination of hyperbaric oxygen therapy and iloprost might be a viable treatment option for severe frostbite, potentially preventing amputation even when treatment is delayed. Canadian patients experiencing severe frostbite could potentially benefit from such a combined approach, though further research is needed to confirm its broader efficacy.

Canadian Relevance

This study has no direct Canadian connection as it describes a case treated in Geneva following an incident in Kyrgystan.

Study Limitations

As a case report, this study's findings are limited by its focus on a single patient, preventing generalizable conclusions.

Was this summary helpful?

Study Details

Study Type Case Report
Category Neurological
Source Pubmed
PubMed ID 35447048
Year Published 2022
Journal High Alt Med Biol
MeSH Terms Adult; Altitude; Arthritis; Frostbite; Humans; Hyperbaric Oxygenation; Iloprost; Male

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.